Ameritas Investment Partners’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.1K | Hold |
4,882
| – | – | ﹤0.01% | 2705 |
|
|
2025
Q1 | $15.8K | Hold |
4,882
| – | – | ﹤0.01% | 2654 |
|
|
2024
Q4 | $27.2K | Hold |
4,882
| – | – | ﹤0.01% | 2499 |
|
|
2024
Q3 | $52.8K | Hold |
4,882
| – | – | ﹤0.01% | 2164 |
|
|
2024
Q2 | $102K | Buy |
4,882
+953
| +24% | +$20K | ﹤0.01% | 1706 |
|
|
2024
Q1 | $125K | Hold |
3,929
| – | – | ﹤0.01% | 1601 |
|
|
2023
Q4 | $79.6K | Hold |
3,929
| – | – | ﹤0.01% | 1890 |
|
|
2023
Q3 | $50K | Buy |
3,929
+1,321
| +51% | +$16.8K | ﹤0.01% | 2107 |
|
|
2023
Q2 | $47.1K | Buy |
2,608
+449
| +21% | +$8.11K | ﹤0.01% | 2089 |
|
|
2023
Q1 | $37.1K | Hold |
2,159
| – | – | ﹤0.01% | 2156 |
|
|
2022
Q4 | $42.8K | Hold |
2,159
| – | – | ﹤0.01% | 2165 |
|
|
2022
Q3 | $17K | Hold |
2,159
| – | – | ﹤0.01% | 2590 |
|
|
2022
Q2 | $15K | Hold |
2,159
| – | – | ﹤0.01% | 2682 |
|
|
2022
Q1 | $33K | Hold |
2,159
| – | – | ﹤0.01% | 2294 |
|
|
2021
Q4 | $47K | Buy |
2,159
+553
| +34% | +$12K | ﹤0.01% | 2163 |
|
|
2021
Q3 | $43K | Buy |
1,606
+973
| +154% | +$26.1K | ﹤0.01% | 2257 |
|
|
2021
Q2 | $15K | Hold |
633
| – | – | ﹤0.01% | 2850 |
|
|
2021
Q1 | $27K | Buy |
+633
| New | +$27K | ﹤0.01% | 2424 |
|